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Abstract
Soy foods contain several components such as isoflavones, calcium and protein that potentially modulate bone turnover 
and increase bone mineral density (BMD) in postmenopausal women. The study is to evaluate the effect of dried bean-
curd supplementation on skeletal health in postmenopausal Chinese women. Three hundred postmenopausal women aged 
50–65 years were assigned into two groups, receiving 100 g dried beancurd or rice cake a day for 2 years. BMD at the lumbar 
spine and right proximal femur were measured with a dual-energy X-ray absorptiometry. The bone turnover biomarkers of 
serum alkaline phosphatase (ALP), bone Gla protein (BGP) and urinary N-telopeptide cross-links of collagen normalized 
for creatinine (NTX/CRT) were also determined. Serum isoflavone concentration was analyzed by high performance liquid 
chromatography. The 2-year dried beancurd supplementation generated a significant increase in lumbar spine BMD. An 
obvious decrease was found in urinary NTX/CRT, and a significant increase was detected in serum isoflavone concentration. 
The dried beancurd supplementation had no effect on changes of right proximal femur BMD and concentrations of serum 
ALP and BGP. Daily supplementation of dried beancurd could increase BMD of lumbar spine, but does not slow bone loss 
at right proximal femur in postmenopausal Chinese women.
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Introduction
Osteoporosis is one of the diseases associated with post-
menopausal syndrome. The menopause-related estrogen 
deficiency accelerates the rate of bone reabsorption and 
decreases the rate of bone formation, causing a rapid loss of 
bone mass and leading to an increased susceptibility to bone 
fractures [1]. It is reported that the osteoporosis prevalence 
is 32.1% for the women over the age of 50 and reaches up to 
51.6% over the age of 65 in China [2].
Hormone replacement therapy has been used to prevent 
and treat osteoporosis in postmenopausal women, which 
could decrease the risk of osteoporosis by about 50% at the 
onset of menopause [3]. However, potential risks of adverse 
effect such as stroke, breast cancer and endometrial can-
cer outweigh the benefits of hormone replacement therapy 
[4]. Soybean and soy products are traditional Chinese food, 
which are the significant source of dietary isoflavones, cal-
cium and protein; the beneficial effects of which on bone 
mass of ovariectomized rat models have been observed [5]. 
Soy protein isolate is effective in preventing bone loss and 
soy isoflavones may stimulate duodenal calcium transport 
and increase intestinal calcium absorption [6]. The potential 
use of phytoestrogens and protein from soy foods to prevent 
the onset of osteoporosis has also been addressed on human 
subjects [7]. A positive association of protein/isoflavones 
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intake with hip BMD as well as total body bone mineral 
content (BMC) of postmenopausal women has been found 
in Ho et al.’s study [8]. Alekel et al.’s work also led to the 
conclusion that soy protein isolate containing 80 mg of iso-
flavones attenuated bone loss in the lumbar region of peri-
menopausal women [9].
However, some human intervention trials have failed 
to find beneficial effects of soy isoflavones and/or protein 
on bone [10, 11]. In a 1-year nutrition intervention study, 
Kenny et al. did not find the significant beneficial effect of 
soy protein and soy isoflavones alone and in combination on 
BMD in postmenopausal women [12]. Most of these stud-
ies with controversial results mainly featured isolated soy 
protein, and purified or concentrated soy isoflavones rather 
than whole soy foods. The limited data available on whole 
soy food consumption and bone status in postmenopausal 
women emanated from epidemiological studies conducted 
in China [13, 14]. Until now, few intervention researches 
have investigated the long-term bone-protective effects of 
whole soy food consumption. Therefore, more rigorous 
study design is required to establish an irrefutable causal 
link between traditional soy food and bone health. The pre-
sent study is to investigate the effect of dried beancurd intake 
on the bone health of postmenopausal Chinese women, to 
testify whether the dried beancurd could delay or prevent the 
occurrence of osteoporosis in Chinese aged women.
Materials and Methods
Participants
We recruited the participants from villages located in north 
of Shandong Province primarily through local advertise-
ments as well as fliers distributed in senior centers of vil-
lages. All eligible participants were recruited between 
December 2015 and January 2017. Participants were 
elderly women aged from 50 to 65 years with a body mass 
index (BMI) 22–28 kg/m2, a follicle stimulating hormone 
(FSH) concentration > 40 IU/L and at least 12 months of 
amenorrhea. Exclusion criteria included abnormal screen-
ing mammogram; significant or pathological endometrial 
hyperplasia; a history of vertebral, hip or wrist fractures, 
cancer, or active liver, kidney, heart, parathyroid and thy-
roid diseases. Women were excluded from the study if they 
were taking hormonal replacement therapy; or phytoestrogen 
treatment within the previous 3 months, or fluoride, calci-
tonin, chronic systemic corticosteroid or any other treatment 
affecting BMD within the previous 6 months. Women were 
also excluded from the study if they had undergone oopho-
rectomy and/or hysterectomy.
As reported in a study on elderly Chinese women [15], 
the variation of lumbar BMD of 0.03 g/m2 is considered to 
be clinically meaningful. The sample size is calculated to be 
112 per group assuming 80% power and a 5% significance 
level. Considering the study period is as long as 2 years, we 
anticipated a 25% dropout rate, recruiting no fewer than 150 
participants in each group. Therefore, 300 elderly women 
aged 50–65 years were recruited for the study.
Study Design
All the participants were randomly assigned into two groups 
by using permuted block randomization method (block 
size = 4). A statistician who was not involved in the clini-
cal procedures of our study conducted the allocation. The 
women in the control group were provided with 100 g rice 
cake a day containing 3.3 g protein, 31 mg calcium and no 
isoflavones. Those in the dried beancurd group were pro-
vided with 100 g dried beancurd a day containing 16.2 g 
protein, 308 mg calcium and 64.4 mg isoflavones.
All the participants were visited by the field staffs every 
2 weeks. The field staffs carefully monitored their compli-
ance with the protocol. To ensure compliance of the partici-
pants, a new food supply was distributed and unused study 
food or empty packages retrieved every 2 weeks to estimate 
compliance rates. The compliance rate was calculated as the 
percentage of total taken study food in the total dispensed 
study food. Participants were requested to suspend taking 
any nutritional supplements that would interfere with the 
outcomes.
Dried beancurd and rice cake were purchased from the 
manufacturer (Xuerun Food Ltd, Anhui, China) and vacuum 
packed. It could be cooked in many ways such as making 
salad, being fried with different vegetables or meats. Par-
ticipants could choose their favorite cooking way depending 
on their own taste.
BMD Measurements
Lumbar spine (L2–L4) and right proximal femur BMD were 
measured by a dual-energy X-ray absorptiometry (DXA) at 
baseline and 6, 12, 18 and 24 months after randomization. 
The long-term stability of this instrument was determined 
by daily measurement of a spine phantom. The BMD of 
each participant was measured by the same certified techni-
cian using the same instrument throughout the entire study 
period. The intra- and inter-assay coefficients of variation 
were 3.7% and 4.2%. The percentage change of BMD rela-
tive to the baseline was determined for each women. The 
effect of treatment on bone is greater in those with lower 
bone mass [16], and hence, it is important to consider base-
line BMD. Percentage change of BMD was calculated as the 
difference between BMD at each time point of intervention 
(6, 12, 18 and 24 months, respectively) and BMD at base-
line, divided by BMD at baseline, and multiplied by 100.
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Biochemical Marker Analysis
Blood samples were collected between 07:00 and 10:00 am 
after the participants fasted overnight. Serum alkaline phos-
phatase (ALP) and bone Gla protein (BGP) were measured 
by using p-nitrophenyl phosphate method and the radioim-
munoassay kit (Incstar, Stillwater, MN), respectively. Serum 
isoflavone concentration was measured by using high per-
formance liquid chromatography (HPLC) as described by 
Craft [17].
Urine samples were collected in polypropylene containers 
and kept cold (4 °C) until each participant’s sample was pro-
cessed. Urinary NTX was analyzed by using the Osteomark 
NTX Direct Response assay (Ostex International, Seattle, 
WA). The average intra-assay variability of each of these 
biomarkers was < 5%.
Dietary Assessment
A 24-h recall technique on three consecutive days was 
employed to assess their food consumption at baseline and 
post-intervention. The participants were asked to visit the 
temporary clinics located in their village for dietary assess-
ment. For the participants who missed the interview, the 
dietitian performed the household survey. Dietary data were 
collected from participants during a face-to-face interview 
with a qualified dietitian. During the interviews, each par-
ticipant was first asked what kinds of foods (including foods 
in three meals, snacks, beverages and supplements) she had 
consumed in the previous day, followed by a question on 
the amount consumed. Serving size and measurement tools 
were provided as references to estimate the amount of food. 
Nutrient intake was estimated based on the Chinese Food 
Component Database [18].
Statistical Analysis
Baseline and clinical characteristics were reported as 
mean ± SDs for normally distributed data, medians for 
data not normally distributed and number (percent) for 
categorical variables. Student’s t test was performed to 
determine the difference of normally distributed data. 
Mann–Whitney U test was used to evaluate the difference 
of not-normally distributed data and χ2-square test for cat-
egorical variables. For analyses of repeated measures of 
BMD, a mixed-effects model was employed. It is a gen-
eralized form of linear regression analysis that allows for 
repeated measures on each participant while accounting 
for the considerable variation across participants in over-
all average BMD and BMD change over time. The age 
and body weight were potential confounding variables for 
BMD [8], which were included as covariates in the analy-
sis. All analyses were done by using SPSS version 18.0 




The enrollment flowchart of participants is displayed in 
Fig. 1. Of the 612 postmenopausal women screened, 300 
were randomly assigned to one of two intervention groups. 
One hundred and seventeen out of 150 participants in the 
dried beancurd group and 112 out of 150 participants in 
the control group completed the study. There were a total 
of 71 participants in two groups discontinuing the study 
because of withdrew consent, moving or violation of the 
protocol.
There were 23 participants with co-morbidities including 
coronary heart disease (n = 11), higher pressure (n = 8), skin 
diseases (n = 3) and retinopathy (n = 1). Ten participants with 
co-morbidities were in the control group and 13 in the dried 
beancurd group. Randomization resulted in baseline equiva-
lence for women in two groups. There were no significant 
differences detected at baseline in age, age at menopause, 
body mass index (BMI), education and family income. Lum-
bar spine and right proximal femur BMD showed no signifi-
cant differences between two groups (Table 1). Compliance 
with the study protocol was confirmed by left-over counts in 
that about 90% of the participants in two groups consumed 
> 85% of the supplemented food. The average consumption 
of dried beancurd was 88.79 ± 4.68 g per day.
Dietary nutrient intakes are presented in Table 2. There 
were no statistical differences between two groups at base-
line for any of these nutrients. Due to the study supplements, 
the isoflavones and calcium levels significantly increased in 
the dried beancurd group as expected. Their protein intake 
also exhibited an increase, but the difference was not sig-
nificant due to the great variance. No changes were found in 
caloric, carbohydrate and fat intakes in either group through 
the study.
For the women who received dried beancurd, a significant 
increase of BMD at lumbar spine was observed during the 
study (Fig. 2). However, no significant difference in BMD 
change at right proximal femur was detected between two 
intervention groups (Fig. 3). As indicated in Table 3, the 
2-year supplementation generated a significant increase 
in serum isoflavone concentration and a decrease in bone 
resorption indicated by urinary NTX/CRT. However, no sig-
nificant difference was observed in serum markers of bone 
formation, i.e., ALP and BGP between two groups.
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Adverse Events
Throughout the intervention, we documented 12 adverse 
events: seven in the control group and five in the dried bean-
curd group. The adverse events included new-onset cardiac 
symptoms (n = 2), increases in blood pressure (n = 4), tran-
sient ischemic attack (n = 1), respiratory infections (n = 4) 
and head injury (n = 1) (Online Resource 1). The overall 
incidence rate of adverse events was not significantly differ-
ent between two groups.
Discussion
The primary purpose of this intervention study was to elu-
cidate the potential bone benefit of incorporating whole soy 
food into the diets of postmenopausal women. After 2-year 
intervention, significant improvement in BMD at lumbar 
spine and marker of bone resorption was observed in the 
women consuming dried beancurd. The excellent com-
pliance of participants with the dried beancurd was con-
firmed by assessing the serum isoflavone concentration at 
24 months.
There is tremendous interest in the effect of soy food 
on BMD or markers of bone turnover in postmenopausal 
women. Some cross-sectional studies suggested that high 
consumption of soy products was associated with increased 
bone mass or decreased bone resorption or fractures [19–23]. 
Somekawa et al.’s study conducted in 478 postmenopausal 
Japanese women showed high intake of soy products was 
related to increased bone mass in postmenopausal women 
[19]. Significant increases in the lumbar spine and Ward’s 
triangle BMD were also found in Chinese postmenopau-
sal women with habitually high intake of dietary isoflavone 
[20]. Kritz-Silverstein found that the usual, unsupplemented 
dietary isoflavone consumption may be protective against 
bone loss in postmenopausal women through a reduction 
in bone resorption [21]. However, a few studies reported 
no significant effects or effects too small to be of clinical 
relevance [24–28]. A double blind, 15-month study by Gal-
lagher did not show any significant positive effect of soy 
protein isolate with varying concentrations of isoflavones on 
BMD in early postmenopausal women [27]. Another double 
blind, 9-month study showed that soy protein did not favora-
bly affect BMD in postmenopausal women [28]. Through-
out these human studies, most of them mainly focused on 
some component of soy food, soy protein or isoflavones, 
not the whole soy food. Only some epidemiological studies 
provided limited data on whole soy food consumption and 
bone status in postmenopausal women [13, 14]. In a large 
perspective cohort study of 24,403 menopausal women in 
Shanghai, the incidence of bone fracture over 4.5 years was 
found to be inversely related to soy food consumption [13]. 
Another prospective cohort study of 63,257 Chinese men 
and women living in Singapore exhibited dietary soy was 
associated with reduced risk of osteoporotic hip fracture for 
women but not for men [14]. However, these studies are not 
intervention trials and cannot establish causality.
Fig. 1  Flow diagram of the 
study in each group. At the 
beginning of the study, there 
were 150 participants in each 
group. At the end, 112 partici-
pants in the control group and 
117 in the dried beancurd group 
completed the study
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Soy, as part of regular diet in China, is not only a rich 
dietary source of isoflavones, but also calcium and protein. 
Tofu is one kind of soy products. During its processing, 
 CaSO4 is added into the soymilk as the coagulant, giving 
rise to the calcium content to 157 mg/100 g and increasing 
its bioavailability [29]. In our study, dried beancurd provided 
to the participants was a reprocessed food from tofu with 
less water and higher calcium, isoflavones and protein. The 
usual diet of the study participants was mainly based on 
plant foods; their average dietary calcium content was as low 
as 361.3 mg, only 36.1% of recommended nutrient intake 
(RNI) [30] with poor bioavailability, which may deteriorate 
the bone status of menopausal women. Furthermore, there 
were only 11 women among 300 participants who took cal-
cium supplements with amount of 200–400 mg per day. The 
percentage of women with calcium supplements was as low 
as 3.7%, much lower than Wang et al.’s study [31]. Since 
our study was conducted in rural areas, the lack of nutrition 
knowledge and poor economic condition may contribute to 
the lower percentage. Seven out of 11 women suspended 
the supplements in the study, three in the control group and 
four in the dried beancurd group. The other four participants 
were excluded from the study because of violation of the 
protocol. On the average, 88.79 g of dried beancurd was 
consumed by the participants in the study, which provided 
additional 273.5 mg calcium and increased their calcium 
intake to 621.4 mg, which may contribute to its benefit of 
bone-protective effect as Messina suggested in his study 
[32]. The average daily intake of isoflavones in our study 
was 57.2 mg, lower than that in other studies reported a 
beneficial effect. However, a study among Chinese women 
conducted by Ho et al. [8] showed that habitual soy iso-
flavone intake of 40 mg had a positive effect on the spine 
BMD for Chinese postmenopausal women over 3 years. And 
Lydeking-Olsen et al.’s finding also suggested that soy food 
with isoflavones in the 50–90 mg range could reduce the 
bone loss of spine by providing an endocrine effect [33]. In 
addition to calcium and isoflavones, 14.4 g protein was also 
Table 1  General characteristics 
of study participants at baseline
Values are n (%) unless otherwise indicated
Mean ± SD (all such values)
BMI body mass index, BMD bone mineral density
a P value indicates difference between the dried beancurd and control groups
Control (n = 112) Dried beancurd (n = 117) P  valuea
Age (years) 59.8 ± 6.4 61.7 ± 5.2 0.21
Height (cm) 155.2 ± 5.9 158.1 ± 6.3 0.56
Weight (kg)
 Baseline 60.8 ± 2.7 61.3 ± 3.9 0.49
 Post-intervention 61.3 ± 3.2 62.0 ± 4.3 0.15
 BMI (kg/m2) 25.3 ± 2.8 24.5 ± 3.0 0.85
 Age of menarche (years) 13.7 ± 3.2 13.2 ± 2.1 0.73
 Age of menopause (years) 48.1 ± 6.1 46.8 ± 5.3 0.65
BMD (g/cm2)
 Lumbar spine 0.810 ± 0.109 0.805 ± 0.098 0.37
 Right proximal femur 0.672 ± 0.081 0.667 ± 0.092 0.18
Family type
 Farmer 73 (65.2%) 86 (73.5%) 0.23
 Worker 3 (2.7%) 4 (3.4%) 0.72
 Teacher 2 (1.8%) 2 (1.7%) 0.17
 Housewife 34 (30.4%) 25 (21.4%) 0.80
Education
 Illiterate 69 (61.6%) 71 (60.7%) 0.11
 Primary school 40 (35.7%) 41 (35.0%) 0.69
 Middle school 2 (1.8%) 5 (4.3%) 0.42
 High school or higher 1 (0.9%) 0 (0) 0.31
Family income per month
 < 1000 Yuan 18 (16.1%) 17 (14.5%) 0.12
 1000–2000 Yuan 32 (28.6%) 36 (30.8%) 0.53
 2000–3000 Yuan 57 (50.9%) 61 (52.1%) 0.26
 > 3000 Yuan 5 (4.5%) 3 (2.6%) 0.49
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Table 2  Daily total energy and macronutrient intakes at baseline and post-intervention in postmenopausal women of two groups
Median; upper, lower quartile values in parentheses (all such values)
a P value indicates the difference between two groups at baseline and post-intervention
b P value indicates the difference from baseline to post-intervention of the control group
c P value indicates the difference from baseline to post-intervention of the dried beancurd group
d The baseline supplemental calcium intake was expressed as mean (n) and range
Control (n = 112) Dried beancurd (n = 117) Pa Pb Pc
Mean Median Mean Median
Energy (kcal)
 Baseline 1601.8 1386.3 (1197.8, 1932.2) 1512.5 1277.2 (1089.6, 1863.1) 0.43
 Post-intervention 1620.5 1505.7 (1257.4, 1967.7) 1717.3 1523.5 (1290.9, 2120.3) 0.32 0.59 0.31
Protein (g)
 Baseline 43.8 39.5 (30.6, 53.7) 43.1 38.7 (25.2, 51.5) 0.56
 Post-intervention 45.2 42.7(32.0, 59.6) 54.9 50.6(39.2, 71.9) 0.10 0.18 0.13
Carbohydrate (g)
 Baseline 284.0 221.6 (163.2, 382.1) 263.6 197.6 (123.8, 366.9) 0.62
 Post-intervention 276.9 208.5 (136.2, 379.8) 298.6 230.6 (183.1, 407.2) 0.28 0.38 0.27
Fat (g)
 Baseline 32.4 28.7 (22.3, 32.5) 31.9 27.3 (19.5, 30.4) 0.78
 Post-intervention 36.9 31.8 (25.6, 37.2) 33.7 29.6 (21.0, 33.9) 0.37 0.56 0.67
Calcium (mg)
 Dietary calcium
  Baseline 389.6 309.7 (172.3, 493.5) 361.3 287.9 (159.8, 456.2) 0.52
  Post-intervention 426.4 342.1 (236.5, 517.5) 621.4 539.2 (413.9, 792.6) 0.02 0.68 < 0.01
 Supplemental calcium
  Baselined 266.7 (3) 200–400 287.5 (4) 200–400
  Post-intervention 0 0
Isoflavones (mg)
 Baseline 31.3 25.1 (12.3, 40.6) 29.8 23.6 (11.7, 34.8) 0.73
 Post-intervention 28.7 22.9 (10.1. 39.2) 76.5 58.9 (48.6, 76.2) < 0.01 0.53 < 0.01
Fig. 2  Mean percentage change in BMD of lumbar spine at each time 
point (6, 12, 18 and 24  months) for two intervention groups: con-
trol, n = 112; dried beancurd, n = 117. Significant differences were 
detected both between treatment (P < 0.001) and time (P = 0.027) by 
the test using a mix-effects model with age and body weight as covar-
iates
Fig. 3  Mean percentage change in BMD of right proximal femur 
at each time point (6, 12, 18 and 24  months) for two intervention 
groups: control, n = 112; dried beancurd, n = 117. No significant 
differences were detected between treatment (P = 0.82) and time 
(P = 0.63) by the test using a mix-effects model with age and body 
weight as covariates
579The Effect of Dried Beancurd on Bone Mineral Density in Postmenopausal Chinese Women: A 2‑Year…
1 3
provided to the participants. In their usual diet, the protein 
intake was only 43 g/day, 60.56% of RNI. Lower dietary 
protein intake possibly influenced bone metabolism and was 
significantly related to greater BMD loss of elderly people 
[34–36]. Some studies have claimed the need for the pres-
ence of soy protein for isoflavones to exert their protective 
effect on BMD [37, 38], which suggested that soy foods pro-
viding 15 g protein/day could have a general sparing effect 
of postmenopausal calcium loss [33]. Taken together, the 
calcium, isoflavones and protein provided with dried bean-
curd may play a combined and synergetic effect to reduce 
the boss loss of postmenopausal women in this study, which 
may contribute to the increase of BMD at lumbar spine.
There were some strengths of our study. The randomized 
controlled trial was as long as 2 years, and sample size was 
229 postmenopausal women, which had sufficient power to 
detect a measurable response to intervention. Whole soy 
food was employed instead of soy isoflavones or protein iso-
late, to evaluate its effect on bone health of postmenopausal 
women. In addition to BMD, biomarkers of bone turnovers 
were also used to investigate the efficacy of soy food on 
skeletal health.
The limitations of this study included that we experienced 
a 23.7% dropout rate, similar to other long-term trials [12]. 
Because of restriction of funding, the BMD at femoral neck 
was not investigated. The femoral neck typically shows less 
variance and is easier to detect change over time due to the 
lesser amounts of arthritis. The lack of data on femoral 
neck reduced the power to estimate the effect of dried bean-
curd. More cautious monitoring in this regard is warranted 
in future studies. And we could not evaluate the potential 
adverse effects of soy-derived isoflavones on breast tissue 
density, endometrial thickness and thyroid function. The 
dried beancurd as a natural food should be safe and benign 
at the amount we provided [39].
Conclusion
In conclusion, a significant effect of dried beancurd supple-
mentation was observed in increase of lumbar spine BMD of 
postmenopausal Chinese women. Our study suggested that 
daily consumption of dried beancurd could prevent bone loss 
and improve bone health of the lumbar spine, which may 
offer a natural and economical intervention for prevention 
of postmenopausal osteoporosis.
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